Takeaway
- There is no difference in the 2-year Radiation Therapy Oncology Group (RTOG) toxicity rates with five fraction s tereotactic body radiotherapy (SBRT) and conventional schedules of radiotherapy in patients with low- to intermediate-risk prostate cancer.
Why this matters
- Prostate SBRT was found to be safe and associated with low...